Citation

Darling RG, Catlett CL, Huebner KD, Jarrett DG. Emerg. Med. Clin. North Am. 2002; 20(2): 273-309.

Affiliation

Operational Medicine Division, US Army Medical Research Institute of Infectious Diseases (USAMRIID), 1425 Porter Street, ATTN: MCMR-UIM-O, Fort Detrick, MD 21702-5011, USA. Robert.Darling@det.amedd.army.mil

Copyright

(Copyright © 2002, Elsevier Publishing)

DOI

unavailable

PMID

12120480

Abstract

Although once considered unlikely, bioterrorism is now a reality in the United States since the anthrax cases began appearing in the fall of 2001. Intelligence sources indicate there are many countries and terrorist organizations that either possess biological weapons or are attempting to procure them. In the future it is likely that we will experience additional acts of bioterrorism. The CDC category A agents represent our greatest challenge because they have the potential to cause grave harm to the medical and public health systems of a given population. Thus, it is imperative that plans be developed now to deal with the consequences of an intentional release of any one or more of these pathogens.

Language: en